These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18222531)
1. Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo. Yang M; Kirley TL Thromb Res; 2008; 122(4):541-8. PubMed ID: 18222531 [TBL] [Abstract][Full Text] [Related]
2. Characterization and importance of the dimer interface of human calcium-activated nucleotidase. Yang M; Horii K; Herr AB; Kirley TL Biochemistry; 2008 Jan; 47(2):771-8. PubMed ID: 18067325 [TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change. Yang M; Kirley TL Biochemistry; 2004 Jul; 43(28):9185-94. PubMed ID: 15248776 [TBL] [Abstract][Full Text] [Related]
4. Calcium-dependent dimerization of human soluble calcium activated nucleotidase: characterization of the dimer interface. Yang M; Horii K; Herr AB; Kirley TL J Biol Chem; 2006 Sep; 281(38):28307-17. PubMed ID: 16835225 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867 [TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases. Smith TM; Hicks-Berger CA; Kim S; Kirley TL Arch Biochem Biophys; 2002 Oct; 406(1):105-15. PubMed ID: 12234496 [TBL] [Abstract][Full Text] [Related]
7. Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs. Surin WR; Prakash P; Barthwal MK; Dikshit M J Pharmacol Toxicol Methods; 2010; 61(3):287-91. PubMed ID: 19961942 [TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment. Drosopoulos JH; Broekman MJ; Islam N; Maliszewski CR; Gayle RB; Marcus AJ Biochemistry; 2000 Jun; 39(23):6936-43. PubMed ID: 10841775 [TBL] [Abstract][Full Text] [Related]
9. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions. Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543 [TBL] [Abstract][Full Text] [Related]
10. The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes. Smith TM; Kirley TL Purinergic Signal; 2006 Jun; 2(2):327-33. PubMed ID: 18404472 [TBL] [Abstract][Full Text] [Related]
11. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347 [TBL] [Abstract][Full Text] [Related]
13. FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis. Kao CY; Lin CN; Yu IS; Tao MH; Wu HL; Shi GY; Yang YL; Kao JT; Lin SW Thromb Haemost; 2010 Aug; 104(2):355-65. PubMed ID: 20539913 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo. Kim CW; Yun JW; Bae IH; Park YH; Jeong YS; Park JW; Chung JH; Park YH; Lim KM Thromb Res; 2011 Jun; 127(6):565-70. PubMed ID: 21420150 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis. Bird JE; Giancarli MR; Allegretto N; Barbera F; Wong P; Schumacher WA; Ogletree ML; Seiffert D Thromb Res; 2008; 123(1):146-58. PubMed ID: 18479740 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-like repeats of SCUBE1 derived from platelets are critical for thrombus formation. Liao WJ; Wu MY; Peng CC; Tung YC; Yang RB Cardiovasc Res; 2020 Jan; 116(1):193-201. PubMed ID: 30722019 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the Anticoagulant and Antithrombotic Properties of the Sphingosine 1-Phosphate Mimetic FTY720. Zhao Z; Wang R; Huo Z; Li C; Wang Z Acta Haematol; 2017; 137(1):1-6. PubMed ID: 27802432 [TBL] [Abstract][Full Text] [Related]
18. Apyrase activity and adenosine diphosphate induced platelet aggregation inhibition by the salivary gland proteins of Culicoides variipennis, the North American vector of bluetongue viruses. Pérez de León AA; Tabachnick WJ Vet Parasitol; 1996 Feb; 61(3-4):327-38. PubMed ID: 8720570 [TBL] [Abstract][Full Text] [Related]
19. The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes. Mosawy S; Jackson DE; Woodman OL; Linden MD Diab Vasc Dis Res; 2014 May; 11(3):174-81. PubMed ID: 24623318 [TBL] [Abstract][Full Text] [Related]